Advantage of post-operative oral administration of UFT (Tegafur and Uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC)

By Tanaka F.   Miyahara R.   Ohtake Y.   Yanagihara K.   Fukuse T.   Hitomi S.   Wada H.  

European Journal of Cardio-Thoracic Surgery, Vol. 14, Iss. 3, 1998-09 ,pp. : 256-262

Elsevier

Access to resources Recommend Favorite

Advantage of postoperative oral administration of UFT (Tegafur and Uracil) for completely resected p-Stage I-IIIa non-small cell lung cancer (NSCLC)

By Maggi G.   Ruffini E.  

European Journal of Cardio-Thoracic Surgery, Vol. 14, Iss. 3, 1998-09 ,pp. : 263-264

Elsevier

Access to resources Recommend Favorite

Postoperative adjuvant chemotherapy with PVM (Cisplatin+Vindesine+Mitomycin C) and UFT (Uracil+Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial

By Wada H.   Miyahara R.   Tanaka F.   Hitomi S.  

European Journal of Cardio-Thoracic Surgery, Vol. 15, Iss. 4, 1999-04 ,pp. : 438-443

Elsevier

Access to resources Recommend Favorite

Immature tumor angiogenesis in high-grade and high-stage renal cell carcinoma

By Kinouchi T.   Mano M.   Matsuoka I.   Kodama S.   Aoki T.   Okamoto M.   Yamamura H.   Usami M.   Takahashi K.  

Urology, Vol. 62, Iss. 4, 2003-10 ,pp. : 765-770

Elsevier

Access to resources Recommend Favorite

Prognostic significance of E-cadherin and -catenin in resected stage I non-small cell lung cancer

By Soo Choi Y.   Mog Shim Y.   Kim S.-H.   Soon Son D.   Lee H.-S.   Young Kim G.   Han J.   Kim J.  

European Journal of Cardio-Thoracic Surgery, Vol. 24, Iss. 3, 2003-09 ,pp. : 441-449

Elsevier

Access to resources Recommend Favorite